Literature DB >> 22367676

Lysyl oxidase and enhancement of cell proliferation and angiogenesis in oral squamous cell carcinoma.

Yin-Hua Shih1, Kuo-Wei Chang, Michael Yuanchien Chen, Cheng-Chia Yu, Dan-Jae Lin, Shih-Min Hsia, Heng-Li Huang, Tzong-Ming Shieh.   

Abstract

BACKGROUND: Lysyl oxidase (LOX) is a copper-dependent enzyme that cross-links collagen and elastin in the extracellular matrix. LOX overexpressed in various tumors. The manner in which LOX affects tumor growth remains controversial.
METHODS: Chemical treatment and gene transfection were used to induce LOX overexpression or inhibition in cell lines SAS and SVEC4-10. LOX mRNA, protein, and activity were confirmed before tube formation assay and tumorigenesis. The microvessels in the tumor section were detected by immunostaining CD31-positive endothelial cells.
RESULTS: LOX overexpression and copper induction of LOX activity increased SVEC4-10 tube formation. LOX silencing and β-aminopropionitrile inhibition of LOX activity had opposite effects. LOX overexpression increased proliferation and proliferating cell nuclear antigen expression. High LOX expression clones increased tumor size in a tumorigenesis model. The microvascular numbers were higher in LOX overexpression tumors than in control tumors.
CONCLUSION: LOX can induce cell proliferation and angiogenesis in oral squamous cell carcinoma.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367676     DOI: 10.1002/hed.22959

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  13 in total

1.  Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.

Authors:  Ichiro Fukumoto; Naoko Kikkawa; Ryosuke Matsushita; Mayuko Kato; Akira Kurozumi; Rika Nishikawa; Yusuke Goto; Keiichi Koshizuka; Toyoyuki Hanazawa; Hideki Enokida; Masayuki Nakagawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2015-10-22       Impact factor: 3.172

2.  LOX expression and functional analysis in astrocytomas and impact of IDH1 mutation.

Authors:  Roseli da Silva; Miyuki Uno; Suely K Nagahashi Marie; Sueli M Oba-Shinjo
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

3.  Identification of the involvement of LOXL4 in generation of keratocystic odontogenic tumors by RNA-Seq analysis.

Authors:  Wei-Peng Jiang; Zi-Han Sima; Hai-Cheng Wang; Jian-Yun Zhang; Li-Sha Sun; Feng Chen; Tie-Jun Li
Journal:  Int J Oral Sci       Date:  2013-12-20       Impact factor: 6.344

4.  Lysyl oxidase-like 4 involvement in retinoic acid epithelial wound healing.

Authors:  Aurélie Comptour; Marion Rouzaire; Corinne Belville; Nicolas Bonnin; Estelle Daniel; Frédéric Chiambaretta; Loïc Blanchon; Vincent Sapin
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

5.  Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution.

Authors:  Benjamin Le Calvé; Audrey Griveau; David Vindrieux; Raphaël Maréchal; Clotilde Wiel; Magali Svrcek; Johann Gout; Lamia Azzi; Léa Payen; Jérôme Cros; Christelle de la Fouchardière; Pierre Dubus; Jérôme Guitton; Laurent Bartholin; Jean-Baptiste Bachet; David Bernard
Journal:  Oncotarget       Date:  2016-05-31

Review 6.  Lysyl Oxidase and the Tumor Microenvironment.

Authors:  Tong-Hong Wang; Shih-Min Hsia; Tzong-Ming Shieh
Journal:  Int J Mol Sci       Date:  2016-12-29       Impact factor: 5.923

7.  Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.

Authors:  Domenico Bellomo; Suzette M Arias-Mejias; Chandru Ramana; Joel B Heim; Enrica Quattrocchi; Sindhuja Sominidi-Damodaran; Alina G Bridges; Julia S Lehman; Tina J Hieken; James W Jakub; Mark R Pittelkow; David J DiCaudo; Barbara A Pockaj; Jason C Sluzevich; Mark A Cappel; Sanjay P Bagaria; Charles Perniciaro; Félicia J Tjien-Fooh; Martin H van Vliet; Jvalini Dwarkasing; Alexander Meves
Journal:  JCO Precis Oncol       Date:  2020-04-14

8.  Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer.

Authors:  Rebecca Kalikawe; Yoshifumi Baba; Daichi Nomoto; Kazuo Okadome; Keisuke Miyake; Kojiro Eto; Yukiharu Hiyoshi; Youhei Nagai; Masaaki Iwatsuki; Takatsugu Ishimoto; Shiro Iwagami; Yuji Miyamoto; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  Cancer Sci       Date:  2019-11-09       Impact factor: 6.716

9.  Evaluation physical characteristics and comparison antimicrobial and anti-inflammation potentials of dental root canal sealers containing hinokitiol in vitro.

Authors:  Yin-Hua Shih; Dan-Jae Lin; Kuo-Wei Chang; Shih-Min Hsia; Shun-Yao Ko; Shyh-Yuan Lee; Shui-Sang Hsue; Tong-Hong Wang; Yi-Ling Chen; Tzong-Ming Shieh
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

10.  Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation.

Authors:  Sifan Wu; Qiongdan Zheng; Xiaoxia Xing; Yinying Dong; Yaohui Wang; Yang You; Rongxin Chen; Chao Hu; Jie Chen; Dongmei Gao; Yan Zhao; Zhiming Wang; Tongchun Xue; Zhenggang Ren; Jiefeng Cui
Journal:  J Exp Clin Cancer Res       Date:  2018-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.